Trial Profile
Multi-center, Open Labelled Phase II trials of UTD1 Alone or in Combination with Capecitabine in Patients with Metastatic or Locally Advanced Breast Cancer Previously Received an Anthrocycline, or a Taxane, and or Capecitabine
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Aug 2016
Price :
$35
*
At a glance
- Drugs Depoxythilone (Primary) ; Capecitabine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 09 Oct 2014 New trial record